## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 3.0% below STRENGTH zone (3.0-6.0%); PEG 2.46 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($591.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Ulta Beauty (ULTA): The 2026 Research Feature – A New Era of Global Expansion**
- Source: FinancialContent | 20260101T143200 | Bullish | Relevance: 100%
- Ulta Beauty (ULTA) has transitioned into a globally focused powerhouse in 2026, navigating past a challenging 2024 with strategic pivots and new leadership under CEO Kecia Steelman. The company is now prioritizing high-margin standalone stores and actively expanding internationally, particularly in Mexico and Europe. Despite risks like the Target partnership exit and retail shrink, Ulta's strong loyalty program, focus on innovation, and robust financial performance position it as a compelling growth story for investors.

**2. Pacer Advisors Inc. Sells 157,910 Shares of Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20260101T111306 | Somewhat-Bullish | Relevance: 100%
- Pacer Advisors Inc. significantly reduced its stake in Ulta Beauty Inc. by selling 157,910 shares, now owning 3,585 shares valued at $1.96 million. This move comes as Ulta Beauty recently exceeded quarterly earnings estimates and received multiple analyst price target upgrades, resulting in a "Moderate Buy" consensus rating with an average target of $576.50. The company's stock currently trades around $605, with institutional investors holding a dominant 90.39% share.

**3. Ulta Beauty (ULTA): The 2026 Research Feature – A New Era of Global Expansion**
- Source: FinancialContent | 20260101T093200 | Bullish | Relevance: 100%
- Ulta Beauty (ULTA) is entering 2026 as a globally focused powerhouse, having navigated a transitional period in 2024 marked by cooling consumer demand and increased competition from Sephora and Amazon. Under new CEO Kecia Steelman, Ulta is prioritizing high-margin standalone stores and international expansion, with successful ventures into Mexico and the acquisition of UK-based Space NK. The company's unique "democratized beauty" model, robust loyalty program, and focus on personalization through AI integration position it for continued growth, despite risks such as the cessation of its Target partnership and potential market saturation in the U.S.

**4. Ulta Beauty stock hits all-time high at 616.51 USD**
- Source: Investing.com | 20260102T150833 | Bullish | Relevance: 100%
- Ulta Beauty Inc. stock reached a new all-time high of $616.51, surpassing its 52-week high, driven by impressive financial performance including a 40.98% return over the past year. Analysts from Evercore ISI, Oppenheimer, Morgan Stanley, and UBS have reiterated or raised their price targets for Ulta Beauty, expressing confidence in its continued growth. The company also announced a new Executive Severance Plan, highlighting corporate developments alongside its strong market presence.

**5. Ulta Beauty Stock: Can a Premium Valuation Still Deliver Beautiful Returns?**
- Source: AD HOC NEWS | 20260102T122446 | Neutral | Relevance: 100%
- Ulta Beauty (ULTA) has shown strong performance despite recent volatility, with its stock price now reflecting a premium valuation. While analysts are mostly positive, they caution that the current price bakes in significant future growth, necessitating consistent strong performance for continued upside. The company's strategic pillars of in-store experience, diverse assortment, and loyalty programs are key to its sustained success.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-02 | Argus Research | $700 | $650 | +8% |
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-02 | Argus Research | main | Buy |
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +7%) could attract flows.
- Momentum building: MRS_10 improving +3.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.46 elevated, pricing in significant growth expectations. Forward P/E 21.9x stretched relative to 11% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +7%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.8B |
| Beta | 0.87 |
| 52W Range | $309.01 - $622.26 |
| Short Interest | 6.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.46 |
| Forward P/E | 21.9 |
| Current P/E | 24.3 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.1% to 3.0% (+3.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.0pp (needs >3.0% for momentum thesis). MRS_5 at 2.5% confirms short-term momentum alignment. Outperforming sector by 4.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.54), momentum weakening. OFD pattern: +FTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.96% (CS: 84) | Neutral |
| RSI_14 | 67.7 | Neutral |
| MACD Histogram | -0.54 | Bearish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.124x | Above |
| vs SMA200 | 1.272x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $620.04
- **Stop Loss:** $591.02 (4.7% risk)
- **Target:** $649.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $12,400.80
- **Portfolio %:** 12.40%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*